首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   181篇
  免费   13篇
  国内免费   2篇
耳鼻咽喉   10篇
儿科学   7篇
基础医学   8篇
口腔科学   47篇
临床医学   12篇
内科学   28篇
神经病学   13篇
特种医学   36篇
外科学   17篇
预防医学   2篇
眼科学   2篇
药学   8篇
肿瘤学   6篇
  2019年   2篇
  2018年   3篇
  2016年   4篇
  2015年   6篇
  2014年   3篇
  2013年   6篇
  2012年   10篇
  2011年   5篇
  2010年   8篇
  2009年   3篇
  2008年   3篇
  2007年   2篇
  2006年   7篇
  2005年   6篇
  2004年   8篇
  2003年   6篇
  2002年   5篇
  2001年   3篇
  2000年   6篇
  1999年   6篇
  1997年   2篇
  1992年   2篇
  1991年   2篇
  1986年   5篇
  1985年   2篇
  1982年   1篇
  1979年   1篇
  1977年   1篇
  1975年   1篇
  1974年   1篇
  1973年   7篇
  1972年   7篇
  1971年   7篇
  1970年   5篇
  1969年   10篇
  1968年   5篇
  1967年   8篇
  1966年   2篇
  1965年   2篇
  1963年   1篇
  1961年   1篇
  1959年   3篇
  1956年   3篇
  1955年   1篇
  1954年   4篇
  1952年   1篇
  1935年   1篇
  1934年   1篇
  1933年   1篇
  1932年   1篇
排序方式: 共有196条查询结果,搜索用时 15 毫秒
151.
152.
153.
Language disorders are identified when a person has difficulty with expressive language, receptive language, or pragmatic language. Speech disorders are identified when a person's voice, fluency, or articulation call attention to the speaker because his or her speech is sufficiently different from the norm. Speech and language development should be consistent with a child's overall development and can be tracked using typical milestone markers. Differential diagnosis is critical to designing appropriate intervention, which should be tailored to the parents' goals along with the child's clinical and educational needs. Early identification and intervention assist in educational planning and are often associated with better long-term outcomes. Any speech-language therapy plan should be designed with measurable goals and consistent monitoring of progress toward those goals.  相似文献   
154.
155.
156.

Purpose

Survivors of childhood cancer are at an increased risk of developing subsequent neoplasms. In long-term survivors of childhood malignancies treated with and without cranial radiation therapy (CRT), undergoing unenhanced magnetic resonance imaging (MRI) of the brain, we estimated detection of intracranial neoplasms.

Methods

To investigate neurocognitive outcomes, 219 survivors of childhood cancer underwent unenhanced screening MRI of the brain. Of the survivors, 164 had been treated for acute lymphoblastic leukemia (ALL) (125 received CRT) and 55 for Hodgkin lymphoma (HL) (none received CRT). MRI examinations were reviewed and systematically coded by a single neuroradiologist. Demographic and treatment characteristics were compared for survivors with and without subsequent neoplasms.

Results

Nineteen of the 219 survivors (8.7 %) had a total of 31 subsequent intracranial neoplasms identified by neuroimaging at a median time of 25 years (range 12–46 years) from diagnosis. All neoplasms occurred after CRT, except for a single vestibular schwannoma within the cervical radiation field in a HL survivor. The prevalence of subsequent neoplasms after CRT exposure was 14.4 % (18 of 125). By noncontrast MRI, intracranial neoplasms were most suggestive of meningiomas. Most patients presented with no specific, localizing neurological complaints. In addition to the schwannoma, six tumors were resected based on results of MRI screening, all of which were meningiomas on histologic review.

Conclusion

Unenhanced brain MRI of long-term survivors of childhood cancer detected a substantial number of intracranial neoplasms. Screening for early detection of intracranial neoplasms among aging survivors of childhood cancer who received CRT should be evaluated.

Implications for Cancer Survivors

The high prevalence of incidentally detected subsequent intracranial neoplasms after CRT in long-term survivors of childhood cancer and the minimal symptoms reported by those with intracranial tumors in our study indicate that brain MRI screening of long-term survivors who received CRT may be warranted. Prospective studies of such screening are needed.  相似文献   
157.
158.
159.
160.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号